Ahmad, Y., Howard, J. P., Arnold, A. D., Madhavan, M. V., Cook, C. M., Alu, M., Mack, M. J., Reardon, M. J., Thourani, V. H., Kapadia, S., Thyregod, H. G. H., Sondergaard, L., Jørgensen, T. H., Toff, W. D., Van Mieghem, N. M., Makkar, R. R., Forrest, J. K., & Leon, M. B. (2023). Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. European Heart Journal, 44(10), 836–852. https://doi.org/10.1093/eurheartj/ehac642

Barbato, E., McEntegart, M., & Gori, T. (2023). The year in cardiovascular medicine 2022: the top 10 papers in interventional cardiology. European Heart Journal, 44(4), 259–261. https://doi.org/10.1093/eurheartj/ehac778

Knops, R. E., Pepplinkhuizen, S., Delnoy, P. P. H. M., Boersma, L. V. A., Kuschyk, J., El-Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kaab, S., Mittal, S., Quast, A.-F. B. E., van der Stuijt, W., Smeding, L., de Veld, J. A., Tijssen, J. G. P., Bijsterveld, N. R., Richter, S., Brouwer, M. A., … Olde Nordkamp, L. R. A. (2022). Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial. European Heart Journal, 43(47), 4872–4883. https://doi.org/10.1093/eurheartj/ehac496

Guerrero, M., Eleid, M. F., Wang, D. D., Pursnani, A., Kodali, S., George, I., Palacios, I., Makkar, R., Satler, L., Kaptzan, T., Lewis, B., Thaden, J., Oh, J., O’Neill, W., & Rihal, C. (2022). 4 year outcomes in a prospective evaluation of transcatheter mitral valve-in-valve, valve-in-ring and valve-in-mitral annular calcification: results from the MITRAL trial. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.2120

Sharma, T., Maehara, A., Ben-Yehuda, O., Maeng, M., Kjoller-Hansen, L., Engstrom, T., Matsumura, M., Frobert, O., Persson, J., Wiseth, R., Larsen, A. I., James, S. K., Ali, Z. A., Stone, G. W., & Erlinge, D. (2022). Biomarkers associated with vulnerable plaques. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1292

Briasoulis, A., Doulamis, I., & Kampaktsis, P. (2022). Characteristics, predictors and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1019

Pracon, R., Spertus, J. A., Broderick, S., Bangalore, S., Rockhold, F. W., Ruzyllo, W., Demchenko, E., Mavromatis, K., Stone, G. W., Mancini, G. B. J., Boden, W. E., Newman, J. D., Reynolds, H. R., Hochman, J. S., & Maron, D. M. (2022). Factors associated with early catheterization in patients randomized to the conservative strategy in the ISCHEMIA Trial. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1215

Bhagra, C. J., Cherikh, W. S., De Filippis, E. M., Ross, H., Stehlik, J., & Macera, F. (2022). Impact of co-morbidities on survival after heart transplant in females of childbearing age: analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1023

Macera, F., Cherikh, W. S., De Filippis, E. M., Ross, H., Stehlik, J., & Bhagra, C. J. (2022). Impact of primary diagnosis on survival after heart transplant in female recipients of childbearing age: an analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1022

Kampaktsis, P., Doulamis, I., Tzani, A., Ruck, J., Zhou, A., Shah, M., Kilic, A., Kourek, C., & Briasoulis, A. (2022). Outcomes of patients after repeat heart transplantation – insights from the UNOS database. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1021

Harano, N., Liang, L. W., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using proteomics profiling. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1727

Lumish, H., Liang, L. W., Hasegawa, K., Maurer, M., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Prediction of worsening heart failure in patients with hypertrophic cardiomyopathy using plasma proteomics profiling. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1723

Lee, C., Liang, L. W., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1724

Eckhardt, C. M., Balte, P. P., Barr, R. G., Bertoni, A. G., Bhatt, S. P., Cuttica, M., Cassano, P. A., Chaves, P., Couper, D., Jacobs, D. R., Kalhan, R., Kronmal, R., Lange, L., Loehr, L., London, S. J., O’Connor, G. T., Rosamond, W., Sanders, J., Schwartz, J. E., … Oelsner, E. C. (2022). Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study. European Heart Journal, 43(23), 2196–2208. https://doi.org/10.1093/eurheartj/ehac205

OUP accepted manuscript. (2022). European Heart Journal. https://doi.org/10.1093/eurheartj/ehac266

Beohar, N., Ailawadi, G., Kotinkaduwa, L. N., Redfors, B., Simonato, M., Zhang, Z., Morgan, L. G., Escolar, E., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Abraham, W. T., Lindenfeld, J., Mack, M. J., & Stone, G. W. (2022). Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial. European Heart Journal, 43(17), 1639–1648. https://doi.org/10.1093/eurheartj/ehac026

Tokgozoglu, L., Orringer, C., Ginsberg, H. N., & Catapano, A. L. (2022). The year in cardiovascular medicine 2021: dyslipidaemia. European Heart Journal, 43(8), 807–817. https://doi.org/10.1093/eurheartj/ehab875

Damy, T., Kristen, A. V., Suhr, O. B., Maurer, M. S., Planté-Bordeneuve, V., Yu, C.-R., Ong, M.-L., Coelho, T., & Rapezzi, C. (2019). Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS). European Heart Journal, 43(5), 391–400. https://doi.org/10.1093/eurheartj/ehz173

Gaudino, M., Di Franco, A., Alexander, J. H., Bakaeen, F., Egorova, N., Kurlansky, P., Boening, A., Chikwe, J., Demetres, M., Devereaux, P. J., Diegeler, A., Dimagli, A., Flather, M., Hameed, I., Lamy, A., Lawton, J. S., Reents, W., Robinson, N. B., Audisio, K., … Benedetto, U. (2021). Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. European Heart Journal, 43(1), 18–28. https://doi.org/10.1093/eurheartj/ehab504

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., Lewis, G. F., Lichtenstein, A. H., Moulin, P., Nordestgaard, B. G., Remaley, A. T., Staels, B., Stroes, E. S. G., Taskinen, M.-R., Tokgözoğlu, L. S., … Catapano, A. L. (2021). Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society. European Heart Journal, 42(47), 4791–4806. https://doi.org/10.1093/eurheartj/ehab551

Kedhi, E., Berta, B., Roleder, T., Hermanides, R. S., Fabris, E., IJsselmuiden, A. J. J., Kauer, F., Alfonso, F., von Birgelen, C., Escaned, J., Camaro, C., Kennedy, M. W., Pereira, B., Magro, M., Nef, H., Reith, S., Al Nooryani, A., Rivero, F., Malinowski, K., … Wojakowski, W. (2021). Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial. European Heart Journal, 42(45), 4671–4679. https://doi.org/10.1093/eurheartj/ehab433

Escaned, J., Cao, D., Baber, U., Nicolas, J., Sartori, S., Zhang, Z., Dangas, G., Angiolillo, D. J., Briguori, C., Cohen, D. J., Collier, T., Dudek, D., Gibson, M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Kunadian, V., … Mehran, R. (2021). Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. European Heart Journal, 42(45), 4624–4634. https://doi.org/10.1093/eurheartj/ehab702

Stefanini, G. G., Briguori, C., Cao, D., Baber, U., Sartori, S., Zhang, Z., Dangas, G., Angiolillo, D. J., Mehta, S., Cohen, D. J., Collier, T., Dudek, D., Escaned, J., Gibson, C. M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., … Mehran, R. (2021). Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. European Heart Journal, 42(45), 4683–4693. https://doi.org/10.1093/eurheartj/ehab533

Ahmad, Y., Howard, J. P., Madhavan, M. V., Bangalore, S., & Stone, G. W. (2021). Reporting data from meta-analysis: snapshot of a moving target. European Heart Journal, 43(7), 699–700. https://doi.org/10.1093/eurheartj/ehab681

Lander, B. S., Zhao, Y., Hasegawa, K., Maurer, M. S., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2021). Comprehensive proteomics profiling identifies patients with late gadolinium enhancement on cardiac magnetic resonance imaging in the hypertrophic cardiomyopathy population. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1764

Shimada, Y. J., Raita, Y., Liang, L. W., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2021). Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1777

Randazzo, M. J., Elias, P., Poterucha, T. J., Sharir, T., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T., Dorbala, S., Di Carli, M., Berman, D. S., Slomka, P. J., & Einstein, A. J. (2021). Impact of age, sex, and cardiac size on the diagnostic performance of myocardial perfusion single-photon emission computed tomography: insights from the REFINE SPECT registry. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.0254

Whelan, C., Coelho, T., Conceicao, I., Brannagan Iii, T. H., Wang, A. K., Polydefkis, M. J., Dyck, P. J., Berk, J. L., Obici, L., Kristen, A., Narayana, A., Olugemo, K., Aquino, P., Benson, M. D., & Gertz, M. (2021). Long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloid polyneuropathy with or without cardiomyopathy: post hoc analysis of NEURO-TTR open-label extension. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.2745

Shimada, Y. J., Raita, Y., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2021). Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1776

Gupta, A., Liu, T., Pounds, C., Sharma, R. P., Yong, C., Krumholz, H. M., & Leon, M. B. (2021). Predictors of increased mortality in untreated moderate aortic stenosis. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1573

Stassen, J., Butcher, S. C., Hirasawa, K., Singh, G. K., Pio, S. M., Amanullah, M. R., Chew, N., Ewe, S. H., Kong, W., Cohen, D. J., Genereux, P., Leon, M. B., Marsan, N. A., Delgado, V., & Bax, J. J. (2021). Prognostic value of left ventricular ejection fraction and symptom severity in patients with moderate aortic stenosis. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1570

Liang, L. W., Raita, Y., Hasegawa, K., Fifer, M. A., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2021). Proteomics profiling reveals distinct molecular subtypes of hypertrophic cardiomyopathy with differential risks of major adverse cardiovascular events. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1765

Argiro, A., Rosenblum, H., Griffin, J., Batra, J., Cappelli, F., Burkhoff, D., Maurer, M., & Olivotto, I. (2021). Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: hemodynamic insights through non-invasive pressure volume analysis. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1558

Liang, L., Kalia, I., Latif, F., Waase, M. P., Sayer, G., Reilly, M. P., & Uriel, N. (2021). The use of telemedicine in cardiogenetics clinical practice during the COVID-19 pandemic. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.3105

Pearsall, C. P., Blitzer, D. B., Zhao, Y. Z., Yamabe, T. Y., Kim, I. K., Bethancourt, C. B., Hu, D. H., Bergsohn, J. B., Kurlanksy, P. K., George, I. G., Smith, C. S., & Takayama, H. T. (2021). Word of caution on adding hemiarch replacement to a proximal aortic aneurysm repair: long-term outcome analysis of over 1,000 patients. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.2264

Mehta, L. S., Elkind, M. S. V., Achenbach, S., Pinto, F. J., & Poppas, A. (2021). Clinician Well-Being—addressing global needs for improvements in the health care field: a joint opinion from the American College of Cardiology, American Heart Association, European Society of Cardiology, World Heart Federation. European Heart Journal, 42(33), 3122–3126. https://doi.org/10.1093/eurheartj/ehab346

Willett, J., Achenbach, S., Pinto, F. J., Poppas, A., & Elkind, M. S. V. (2021). The tobacco endgame—eradicating a worsening epidemic. European Heart Journal, 42(32), 3044–3048. https://doi.org/10.1093/eurheartj/ehab245